Advances in Naturally and Synthetically Derived Bioactive Sesquiterpenes and Their Derivatives: Applications in Targeting Cancer and Neurodegenerative Diseases
Molecules · 2025
DOI: 10.3390/molecules30214302 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Liana R Cutter und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Fordham University, 441 East Fordham Road, Bronx, New York, NY 10458, USA. Hauptthemen laut MEDLINE: Sesquiterpenes, Neurodegenerative Diseases, Neoplasms, Biological Products. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henry Luce Foundation, Fordham University.
Abstract (Originalsprache)
Sesquiterpenes are a diverse class of natural products that have garnered considerable interest for their potent bioactivity and structural variability. This review highlights advances in the derivatization of various sesquiterpene lactones, quinones, and alcohols, particularly in targeting cancer and neurodegenerative diseases. The structural modifications discussed include the incorporation of triazole, arylidene, or thiol moieties with eudesmane, guaiane, and germacranolide-type sesquiterpenes, among others. In addition, the conjugation with chemotherapeutics, as well as the development of nanoscale therapeutics, is also discussed. Such modifications have expanded the pharmacological potential, enabling improved specificity, cytotoxicity profiles, and sensitization toward tumor cells. Additionally, sesquiterpenes such as parthenolide (20), pterosinsade A (176), and cedrol (186) have demonstrated potential in mitigating neurodegeneration via anti-inflammatory and antioxidant signaling pathway-modulation mechanisms, with potential applications in Alzheimer’s, Parkinson’s, and ALS diseases. Mechanistic insights into redox signaling modulation, NF-κB inhibition, ROS regulation, and disruption of aggregation underscore their multifaceted modes of action. This review highlights the translational promise of sesquiterpene derivatives as dual-action agents for potential drug development in a plethora of diseases that are caused by inflammation and free-radical damage. It provides a framework for future rational design of multifunctional drug candidates and therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, Fordham University, 441 East Fordham Road, Bronx, New York, NY 10458, USA.
ORCID-Profile: Liana R Cutter, Alexandra R Ren, Ipsita A Banerjee
Förderung
- Henry Luce Foundation
- Fordham University
Zitieren
APA
Cutter, L. R., Ren, A. R., & Banerjee, I. A. (2025). Advances in Naturally and Synthetically Derived Bioactive Sesquiterpenes and Their Derivatives: Applications in Targeting Cancer and Neurodegenerative Diseases. Molecules. https://doi.org/10.3390/molecules30214302
Vancouver
Cutter LR, Ren AR, Banerjee IA. Advances in Naturally and Synthetically Derived Bioactive Sesquiterpenes and Their Derivatives: Applications in Targeting Cancer and Neurodegenerative Diseases. Molecules. 2025. doi:10.3390/molecules30214302
BibTeX
@article{Cutter2025,
author = {Cutter, Liana R and Ren, Alexandra R and Banerjee, Ipsita A},
title = {Advances in Naturally and Synthetically Derived Bioactive Sesquiterpenes and Their Derivatives: Applications in Targeting Cancer and Neurodegenerative Diseases},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30214302}
}
EUVIMED